نتایج جستجو برای: bacillus calmette guerin

تعداد نتایج: 57621  

Journal: :The Journal of urology 2006
Ofer Yossepowitch Scott E Eggener Bernard H Bochner S Machele Donat Harry W Herr Guido Dalbagni

PURPOSE We assessed the safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients. MATERIALS AND METHODS We retrospectively reviewed the charts of 697 patients treated with bacillus Calmette-Guerin instillations at our institution from 1991 to 2004. In 24 patients (3.5%) an underlying comorbidity directly affecting the immune ...

Journal: :hepatitis monthly 0
maryam yazdanian hepatitis and aids department, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166969291 arash memarnejadian hepatitis and aids department, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166969291 ; hepatitis and aids department, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166969291 mehdi mahdavi virology department, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166496682 seyed mehdi sadat hepatitis and aids department, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166969291 fatemeh motevali hepatitis and aids department, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166969291 rouhollah vahabpour hepatitis and aids department, pasteur institute of iran, tehran, ir iran. tel/fax: +98-2166969291

conclusions results showed that hcvcp + bcg induced a moderate ctl and mixed th1/th2 immune responses with higher levels of cell proliferation and ifn-γ secretion, indicating that bcg may have a better outcome when formulated in hcvcp-based subunit vaccines. results expression and purification of core protein around the expected size (21 kda) was confirmed by western blotting. the hcvcp + bcg v...

2009
Miguel Álvarez-Múgica Jesús M Fernández Gómez Verónica Bulnes Vázquez Antonio Jalón Monzón José M Fernández Rodríguez Laura Rodríguez Robles

INTRODUCTION Bacillus Calmette-Guerin (BCG) is a live attenuated strain of Mycobacterium bovis that has been used to treat urothelial carcinoma since 1976, and has been reported to eradicate disease in more than 70% of patients with in situ and stage I disease. To the best of our knowledge, we report the first case of disseminated bacillus Calmette-Guerin infection causing multiple abscesses af...

2012
Tom H. M. Ottenhoff Stefan H. E. Kaufmann

In this review we discuss recent progress in the development, testing, and clinical evaluation of new vaccines against tuberculosis (TB). Over the last 20 years, tremendous progress has been made in TB vaccine research and development: from a pipeline virtually empty of new TB candidate vaccines in the early 1990s, to an era in which a dozen novel TB vaccine candidates have been and are being e...

2016
Yili Liu

© Translational Andrology and Urology. All rights reserved. Transl Androl Urol, 2016;5(S1) tau.amegroups.com Cite this abstract as: Cui J, Chen S, Yang Y, Zhu Y, Chen F, Shi B. Combination of intravesical chemotherapy and Bacillus Calmette-Guerin versus Bacillus Calmette-Guerin monotherapy in intermediateand high-risk non-muscle invasive bladder cancer: a systematic review and meta-analysis. Tr...

Journal: :international journal of pediatrics 0
mohammad sadegh rezai associate professor, infectious diseases research center with focus on nosocomial infection, mazandaran university of medical sciences, sari, iran. fatemeh ahangarkani phd student in medical mycology, antimicrobial resistance research center, student research committee, mazandaran university of medical sciences, sari, iran roghaye sadeghi resident of pediatrics, infectious diseases research center with focus on nosocomial infection, mazandaran university of medical sciences, sari, iran. mohammad reza mahdavi assistant professor, thalassemia research center, hemoglobinopathy institute, mazandaran university of medical sciences, sari, iran.

background: although the efficacy of bacillus calmette-guerin (bcg) vaccine in the prevention of tuberculosis has been noted consistently, the use of bcg vaccine is not without risk. in this study we aimed to evaluate immunologically, children with complication of bcg vaccination in north of iran.materials and methods: this case-control study began in 30 jan 2013 and was completed in 2 jul 2015...

Journal: :The Pediatric infectious disease journal 2001
J S Goraya V S Virdi

Various treatments have been used to decrease the risk of suppuration; the most troublesome complication of Calmette-Guerin bacillus adenitis, but results are controversial. Metaanalysis of four randomized controlled trials revealed no significant difference in the frequency of suppuration between the treatment and control groups for all treatments [relative risk (RR), 1.10; 95% confidence inte...

Journal: :Journal of clinical microbiology 2012
Hajime Kanamori Katsuhiko Isogami Takashi Hatakeyama Hiroo Saito Kazuyoshi Shimada Bine Uchiyama Noboru Aso Mitsuo Kaku

We report a case of chest wall abscess caused by Mycobacterium bovis BCG that arose as a complication 1 year after intravesical BCG instillation. We identified M. bovis BCG Tokyo 172 in the abscess by PCR-based typing of Mycobacterium tuberculosis complex and analysis of variable number of tandem repeats data.

2014
Makoto Tobiume Tsutomu Shinohara Takahira Kuno Shinji Mukai Keishi Naruse Nobuo Hatakeyama Fumitaka Ogushi

BACKGROUND Pneumonitis is a rare complication of bacillus Calmette-Guerin (BCG) immunotherapy seen in patients with urothelial cancer following the repeated administration of BCG. However, no case of BCG-induced pleurisy has been reported. CASE PRESENTATION We here report the first case of pneumonitis with lymphocytic pleurisy following bacillus Calmette-Guerin (BCG) immunotherapy. Although m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید